目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?

8 Company Profiles
8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. BioNTech SE
8.4. Bayer AG
8.5. Novartis AG
8.6. Takeda Pharmaceutical Company Limited

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Global biotechnology industry value: $ billion, 2016-21
Table 2: Global biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: Global biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Global biotechnology industry geography segmentation: $ billion, 2021
Table 5: Global biotechnology industry value forecast: $ billion, 2021-26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: F. Hoffmann-La Roche Ltd: key facts
Table 11: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 12: F. Hoffmann-La Roche Ltd: Key Employees
Table 13: BioNTech SE: key facts
Table 14: BioNTech SE: Annual Financial Ratios
Table 15: BioNTech SE: Key Employees
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Novartis AG: key facts
Table 21: Novartis AG: Annual Financial Ratios
Table 22: Novartis AG: Key Employees
Table 23: Novartis AG: Key Employees Continued
Table 24: Takeda Pharmaceutical Company Limited: key facts
Table 25: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 26: Takeda Pharmaceutical Company Limited: Key Employees
Table 27: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 28: Global exchange rate, 2017-21

List of Figures
Figure 1: Global biotechnology industry value: $ billion, 2016-21
Figure 2: Global biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Global biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the global biotechnology industry, 2021
Figure 6: Drivers of buyer power in the global biotechnology industry, 2021
Figure 7: Drivers of supplier power in the global biotechnology industry, 2021
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2021
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2021
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2021